Silence Therapeutics's total assets for Q3 2025 were £146.79M, a decrease of -11.16% from the previous quarter. SLN total liabilities were £72.73M for the fiscal quarter, a 2.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.